Showing 3261-3270 of 3314 results for "".
- Allergan Shareholders Urge Company to Overhaul Management Structure; Split Role of Chairman and CEOhttps://modernod.com/news/allergan-shareholders-urge-company-to-overhaul-management-structure-split-role-of-chairman-and-ceo/2480116/In a letter sent to Allergan’s board of directors on Tuesday, two company shareholders, Appaloosa Management and Senator Investment Group, called on the drugmaker to divide the roles of chief executive officer and chairman, currently held by Brent Saunders. The investors also urged Allergan
- Orasis Pharmaceuticals Closes $13 Million Series B Financinghttps://modernod.com/news/orasis-pharmaceuticals-closes-13-million-series-b-financing/2480119/Privately-held Orasis Pharmaceuticals announced the closing of a $13 million Series B financing to be used to advance Orasis’s lead product candidate, CSF-1, an eye drop being developed for the treatment of presbyopia symptoms, through completion of its phase 2b clinical trial. The proceeds will
- Caution Needed With Artificial Intelligence in Medicine, Experts Warnhttps://modernod.com/news/caution-needed-with-artificial-intelligence-in-medicine-experts-warn/2480125/Current hype surrounding machine learning and artificial intelligence (AI) in medicine is enormous, with seemingly daily headlines declaring that some new model will change how a disease is diagnosed or treated. Experts are more cautious, though, with several speakers at the recent
- Miracles in Sight Seeks to Expand Adoption of Innovative Surgery With Prepared DMEK Graftshttps://modernod.com/news/miracles-in-sight-seeks-to-expand-adoption-of-innovative-surgery-with-prepared-dmek-grafts/2480128/Across the world, Descemet Membrane Endothelial Keratoplasty (DMEK) is becoming the standard of care for endothelial dysfunction. Miracles In Sight (MIS), a nonprofit eye bank that recovers, processes, and distributes ocular tissue, is helping reduce the learning curve for this new surgical techn
- Rayner Receives CE Mark for Its Hydrophobic Fully Preloaded IOL Injection Systemhttps://modernod.com/news/rayner-receives-ce-mark-for-its-hydrophobic-fully-preloaded-iol-injection-system/2480142/Rayner has received European CE Mark for its first hydrophobic fully preloaded IOL injection system. The RayOne Hydrophobic IOL is made of a new proprietary material that is glistening-free, with a patented “Cornerstone” lens shape for stability during lens delivery and post-implantat
- Tear Film Innovations Completes $8.5 Million Series B Fundinghttps://modernod.com/news/tear-film-innovations-completes-8-5-million-series-b-funding/2480145/Tear Film Innovations announced it has completed a $8.5 million Series B Preferred Stock funding round led by Visionary Ventures Fund LP and Bluestem Capital. “This successful funding round completes the capitalization for our growth strategy. We are currently making key hires to meet the
- Researchers Identify Genetic Variants that May Predict Glaucoma Riskhttps://modernod.com/news/researchers-identify-genetic-variants-that-may-predict-glaucoma-risk/2480146/A study led by scientists from King’s College London, University College London, Massachusetts Eye and Ear, and Harvard Medical School has identified 133 genetic variants that could help predict the risk of developing glaucoma, the world’s leading cause of incurable blindness.
- California Optometrists Caution Patients About Unapproved, Online Vision Tests After FDA Warninghttps://modernod.com/news/california-optometrists-caution-patients-about-unapproved-online-vision-tests-after-fda-warning/2480161/The California Optometric Association cautioned California consumers that self-administered “vision tests” conducted online come with significant safety concerns and appear to violate federal law, according to a news release. In a letter to the California Attorney General, the organization
- Eye Health America Appoints Cathleen McCabe, MD, as Chief Medical Officerhttps://modernod.com/news/eye-health-america-appoints-cathleen-mccabe-md-as-chief-medical-officer/2480162/Eye Health America (EHA) has appointed Cathleen McCabe, MD, as its chief medical officer. As the newest member of EHA’s executive leadership team, Dr. McCabe will be responsible for the development, implementation, and continuation of best practices across EHA’s group practices and ambulatory sur
- Takeda Reaches Deal to Buy Shire for $62 Billionhttps://modernod.com/news/takeda-reaches-deal-to-buy-shire-for-around-62-billion/2480166/After several failed attempts, Japanese drugmaker Takeda Pharmaceutical managed to reach an agreement to acquire Shire in a $62 billion deal. The offer is approximately 46 percent cash and 54 percent stock, leaving Shire shareholders owning around half of the combined group. Shire investors will